D-0501-2023 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0501-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: a) 399 bottles, b)445 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2023
Initiation Date
Mar 20, 2023
Termination Date
Oct 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 399 bottles, b)445 bottles

Product description

Rosuvastatin 10mg tablets, packaged in a) 30-count bottles (NDC 70518-0375-03 and 70518-0375-01) and b) 90-count bottles (NDC 70518-0375-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reason for recall

cGMP Deviations

Distribution pattern

RemedyRepack distributed product to consignees nationwide within the United States

Code information

Lot#: a) NDC 70518-0375-03: J0674788-011123, Exp. Date 01/31/2024; J0664118-112922 J0664118-112922, Exp. Date 12/31/2023; J0653727-101722, Exp. Date 10/31/2023. NDC 70518-0375-01: B2057931-011223, Exp. Date 07/31/2025 b) Lot #: B2075815-012523, Exp. Date 09/30/2025; B2011634-121322, Exp. Date 07/31/2025 B1970205-112022, Exp. Date 06/30/2024; B1862598-092022, Exp. Date 03/31/2024; B2077226-012523, B2070444-012023, Exp. Date 07/31/2025.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0501-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0501-2023. Report a data issue: hello@regdatalab.com.